Accordingly, elevated expression of RPs and Eif4a1 was also detected in both prostate primary and metastatic tumor cells, aligning with upregulated XPO1, HGF/MET, and Wnt/β-catenin downstream target expression. This evidence concerns the gene MET and metastatic neoplasm.